|
Dr. Nino is Director, Regulatory Affairs at ICON Development Solutions and brings more than eight years of regulatory experience in new drug development to the company.
Before joining ICON, Dr. Nino held senior positions in regulatory affairs at Hana Biosciences Inc., as the head of the regulatory department and at Genentech Inc., where she led the registration strategy for Tarceva and Rituxan.
Prior to Genentech, Dr. Nino was at Pfizer Global Research and Development and at Agouron Pharmaceuticals Inc., where she was involved in regulatory strategy and registration with domestic and international health authorities in the therapeutic areas of Oncology, HIV and Ophthalmology. Dr. Nino also served as a hospital pharmacist at La Pitie Salpetriere Hospital (Paris) and New York University Medical Center.
Dr. Nino received her Pharm.D. and masters degree in International Drug Development and Registration from the University of Pharmacy of Paris. | 